Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain.

Cerutti, Gabriele; Guo, Yicheng; Wang, Pengfei; Nair, Manoj S; Huang, Yaoxing; Yu, Jian; Liu, Lihong; Katsamba, Phinikoula S; Bahna, Fabiana; Reddem, Eswar R; Kwong, Peter D; Ho, David D; Sheng, Zizhang; Shapiro, Lawrence

Cerutti, Gabriele; Guo, Yicheng; Wang, Pengfei; Nair, Manoj S; Huang, Yaoxing; Yu, Jian; Liu, Lihong; Katsamba, Phinikoula S; Bahna, Fabiana; Reddem, Eswar R; Kwong, Peter D; Ho, David D; Sheng, Zizhang; Shapiro, Lawrence.

bioRxiv ; 2021 Jun 29.

Article em En | MEDLINE | ID: mdl-34230927

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259903
https://dx.doi.org/10.1101/2021.06.29.450397

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2021 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259903
https://dx.doi.org/10.1101/2021.06.29.450397

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2021 Tipo de documento: Article